These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 917167)

  • 41. [Tetany as a sole manifestation in a patient with Bartter's syndrome and a successful treatment with indomethacin].
    Fujihara K; Miyoshi T; Yamaguchi Y; Araki T; Tanaka K
    Rinsho Shinkeigaku; 1990 May; 30(5):529-32. PubMed ID: 2401113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.
    Lechi A; Mantero F; Opocher G; Armanini D; Lechi C; Covi G
    J Endocrinol Invest; 1981; 4(1):17-20. PubMed ID: 7016967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Indomethacin for Bartter's syndrome.
    Zancan L; Zacchello F; Mantero F
    Lancet; 1976 Dec; 2(7999):1354. PubMed ID: 63823
    [No Abstract]   [Full Text] [Related]  

  • 44. [Bartter's syndrome: the long term effects of indomethacin on growth (author's transl)].
    Floret D; David M; Roux A; Hage GN; Teyssier G
    Nouv Presse Med; 1979 Jan; 8(1):17-21. PubMed ID: 122007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversal of altered vascular responsiveness in Bartter's syndrome by indomethacin treatment.
    Shimoyama R
    J Clin Endocrinol Metab; 1980 Oct; 51(4):908-11. PubMed ID: 6999001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of indomethacin upon the renin--angiotensin system in patients with Bartter's syndrome.
    Vierhapper H; Waldhäusl W
    Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):119-24. PubMed ID: 6780358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
    Horký K; Schreiber V; Dvoráková J
    Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
    Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K
    Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
    [No Abstract]   [Full Text] [Related]  

  • 49. Indomethacin and atrial natriuretic peptide in pseudo-Bartter's syndrome.
    Sasaki H; Okumura M; Kawasaki T; Kangawa K; Matsuo H
    N Engl J Med; 1987 Jan; 316(3):167. PubMed ID: 2948126
    [No Abstract]   [Full Text] [Related]  

  • 50. Elevated levels of plasma atrial natriuretic peptide in Bartter's syndrome fall to normal with indomethacin: implications for atrial natriuretic peptide regulation in man.
    Gordon RD; Tunny TJ; Klemm SA; Hamlet SM
    J Hypertens Suppl; 1986 Dec; 4(6):S555-8. PubMed ID: 2956391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for a prostaglandin-independent defect in chloride reabsorption in the loop of Henle as a proximal cause of Bartter's syncrome.
    Gill JR; Bartter FC
    Am J Med; 1978 Nov; 65(5):766-72. PubMed ID: 360836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bartter's syndrome--limelight on prostaglandins.
    Vaisrub S
    JAMA; 1978 Jan; 239(2):137-8. PubMed ID: 412985
    [No Abstract]   [Full Text] [Related]  

  • 53. Bartter's syndrome. New insights into pathogenesis and treatment.
    Solomon RJ; Brown RS
    Am J Med; 1975 Oct; 59(4):575-83. PubMed ID: 1166859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacologic studies in Bartter's syndrome: opposite effects of treatment with antikaliuretic and antiprostaglandin drugs. Part I.
    Simatupang TA; Radó JP; Boer P; Geyskes GG; Vos J; Dorhout Mees EJ
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):14-8. PubMed ID: 631965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bartter's syndrome. A case report.
    Kumin CG; Kirsten GF
    S Afr Med J; 1982 May; 61(18):677-8. PubMed ID: 7079868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bartter's syndrome in newborn treated with indomethacin.
    Daga SR; Patole S; Deokate S; Bhatnagar S
    Indian Pediatr; 1989 Jan; 26(1):79-81. PubMed ID: 2759699
    [No Abstract]   [Full Text] [Related]  

  • 57. [The role of prostaglandins in the pathogenesis of Bartter's syndrome].
    Radó J; Simatupang T; Boer P; Mees EJ
    Orv Hetil; 1981 Jun; 122(25):1519-27. PubMed ID: 7312332
    [No Abstract]   [Full Text] [Related]  

  • 58. A case of adult-onset Bartter's syndrome.
    Park JW; Chung YJ; Yeum CH; Lee JJ; Yoo KS; Kim SW; Kim NH; Choi KC; Kang YJ
    Korean J Intern Med; 1995 Jan; 10(1):60-3. PubMed ID: 7626559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
    Halushka PV; Wohltmann H; Privitera PJ; Hurwitz G; Margolius HS
    Ann Intern Med; 1977 Sep; 87(3):281-6. PubMed ID: 900671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of captopril on blood pressure, renal function, the electrolyte balance and the renin-angiotensin system in Bartter's syndrome.
    Aurell M; Rudin A
    Nephron; 1983; 33(4):274-8. PubMed ID: 6341865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.